JP2009529554A5 - - Google Patents

Download PDF

Info

Publication number
JP2009529554A5
JP2009529554A5 JP2008558713A JP2008558713A JP2009529554A5 JP 2009529554 A5 JP2009529554 A5 JP 2009529554A5 JP 2008558713 A JP2008558713 A JP 2008558713A JP 2008558713 A JP2008558713 A JP 2008558713A JP 2009529554 A5 JP2009529554 A5 JP 2009529554A5
Authority
JP
Japan
Prior art keywords
ceramic
pharmaceutical composition
densified
derivative
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008558713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009529554A (ja
JP5216601B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/002250 external-priority patent/WO2007104549A2/en
Publication of JP2009529554A publication Critical patent/JP2009529554A/ja
Publication of JP2009529554A5 publication Critical patent/JP2009529554A5/ja
Application granted granted Critical
Publication of JP5216601B2 publication Critical patent/JP5216601B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008558713A 2006-03-14 2007-03-14 生体吸収性の制御放出組成物 Expired - Fee Related JP5216601B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200600361 2006-03-14
DKPA200600361 2006-03-14
PCT/EP2007/002250 WO2007104549A2 (en) 2006-03-14 2007-03-14 Bioresorbable controlled-release composition

Publications (3)

Publication Number Publication Date
JP2009529554A JP2009529554A (ja) 2009-08-20
JP2009529554A5 true JP2009529554A5 (cg-RX-API-DMAC7.html) 2010-05-13
JP5216601B2 JP5216601B2 (ja) 2013-06-19

Family

ID=36602790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008558713A Expired - Fee Related JP5216601B2 (ja) 2006-03-14 2007-03-14 生体吸収性の制御放出組成物

Country Status (17)

Country Link
US (1) US8999389B2 (cg-RX-API-DMAC7.html)
EP (1) EP1996160B8 (cg-RX-API-DMAC7.html)
JP (1) JP5216601B2 (cg-RX-API-DMAC7.html)
KR (1) KR101378174B1 (cg-RX-API-DMAC7.html)
CN (1) CN101431984B (cg-RX-API-DMAC7.html)
AT (1) ATE460154T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007224651B8 (cg-RX-API-DMAC7.html)
CA (1) CA2644429C (cg-RX-API-DMAC7.html)
DE (1) DE602007005231D1 (cg-RX-API-DMAC7.html)
DK (1) DK1996160T3 (cg-RX-API-DMAC7.html)
ES (1) ES2342123T3 (cg-RX-API-DMAC7.html)
IL (1) IL193973A (cg-RX-API-DMAC7.html)
MX (1) MX2008011606A (cg-RX-API-DMAC7.html)
PL (1) PL1996160T3 (cg-RX-API-DMAC7.html)
RU (1) RU2405537C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007104549A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200807881B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL181834A (en) 2006-04-02 2011-04-28 Iscar Ltd Cutting head and adaptor
MX2011005243A (es) * 2008-11-27 2011-08-08 Lidds Ab Uso de carboximetilcelulosa para controlar la eyectabilidad y el tiempo de solidificacion de las composiciones que comprenden una o mas ceramicas biorreabsorbibles.
JP2012517466A (ja) * 2009-02-12 2012-08-02 アドゥロ・マテリアル・アクチボラゲット 制御されたドラッグデリバリーのための生体分解性担体を含む組成物
PT3086784T (pt) * 2013-12-23 2019-06-27 Bcn Peptides Sa Análogos de bicalutamida ou (s)-bicalutamida como compostos ativadores de exocitose para utilização no tratamento de um distúrbio de armazenamento lisossómico ou glicogenose
JP6758325B2 (ja) 2015-06-04 2020-09-23 クリティテック・インコーポレイテッド タキサン粒子およびその使用
CN114767860A (zh) 2016-04-04 2022-07-22 克里蒂泰克公司 实体肿瘤治疗方法
EP3498675A1 (en) 2016-10-17 2019-06-19 Lidds AB A calcium sulphate hemihydrate with unique properties
CA3063420A1 (en) 2017-06-09 2018-12-13 Crititech, Inc. Treatment of epithelial cysts by intracystic injection of antineoplastic particles
AU2018284247B2 (en) 2017-06-14 2020-04-30 Crititech Inc. Methods for treating lung disorders
CA3076919A1 (en) 2017-10-03 2019-04-11 Crititech, Inc. Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
RU2683255C1 (ru) * 2018-03-06 2019-03-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук Биоактивный композиционный материал для замещения костных дефектов и способ его получения
WO2019170912A1 (en) 2018-03-09 2019-09-12 Lidds Ab Bioresorbable controlled-release compositions with sting modulating molecules

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797758A (en) * 1972-06-16 1974-03-19 Giulini Gmbh Geb Method of producing finely dispersed alpha calcium sulfate hemihydrate
JP2702953B2 (ja) 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
EP0376331A3 (en) 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
CA2268156C (en) * 1996-10-16 2007-05-29 Etex Corporation Bioceramic compositions
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
SE9704400D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Porous inorganic particles as carriers for drug substances
US6030635A (en) * 1998-02-27 2000-02-29 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
GB0020610D0 (en) 2000-08-21 2000-10-11 Dytech Corp Ltd Uses of porous carriers
US6730324B2 (en) * 2001-04-20 2004-05-04 The University Of British Columbia Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
SE522749C2 (sv) * 2002-03-04 2004-03-02 Cerbio Tech Ab Ytbeläggningsförfarande, ytbelagd anordning och biokompatibel ytbeläggning
PL1680089T3 (pl) 2003-10-22 2014-03-31 Lidds Ab Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków

Similar Documents

Publication Publication Date Title
RU2008140519A (ru) Биологически рассасывающаяся композиция с контролируемым высвобождением
JP4969586B2 (ja) マルチプルユニット型徐放性経口製剤およびその製造方法
JP5592547B2 (ja) 薬物送達組成物
US20090061003A1 (en) Carriers for drug delivery
CA2488860A1 (en) Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former
RU2009110253A (ru) Способ приготовления таблеток прамипексолдигидрохлорида, обладающих высокой стабильностью при хранении
CN101219120B (zh) 替米沙坦分散片及其制备方法
EP2494963A1 (en) Combinations of valsartan and amlodipine
JP2002522472A (ja) ピリジン−2−イルメチルスルフィニル−1h−ベンズイミダゾールの経口投与形
CN113662919B (zh) 一种稳定的头孢克肟片剂及其制备方法
WO2017107242A1 (zh) 药物组合物及其制备方法和应用
JP2013544272A5 (cg-RX-API-DMAC7.html)
JP2008517988A5 (cg-RX-API-DMAC7.html)
CN101204389A (zh) 一种含有重酒石酸卡巴拉汀的药物组合物及其制备方法
CN101507716A (zh) 硝苯地平缓释制剂及其制备方法
CN105816436A (zh) 一种泮托拉唑肠溶微丸、泮托拉唑肠溶缓控释片剂及其制备方法
CN110063942B (zh) 琥珀酸曲格列汀固体制剂及其制备方法
CN112315932A (zh) 一种奥美沙坦酯片及其制备方法
CN114099452B (zh) 琥珀酸索利那新片剂及其制备方法
CN100551369C (zh) 一种含有西洛他唑的缓释制剂及其制备方法
KR102698893B1 (ko) 덱스란소프라졸을 포함하는 경구용 정제 조성물, 이를 포함하는 경구용 정제 및 그 제조방법
CN104546785A (zh) 泼尼松脉冲释放片
CN118717689A (zh) 苯溴马隆片的绿色工艺
CN103751784A (zh) 包含质子泵抑制剂的双层片剂
WO2011154013A1 (en) Pharmaceutical composition comprising fenofibric acid